These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35244402)

  • 1. Discovery and Structure-Based Optimization of Novel Atg4B Inhibitors for the Treatment of Castration-Resistant Prostate Cancer.
    Kudo Y; Endo S; Fujita M; Ota A; Kamatari YO; Tanaka Y; Ishikawa T; Ikeda H; Okada T; Toyooka N; Fujimoto N; Matsunaga T; Ikari A
    J Med Chem; 2022 Mar; 65(6):4878-4892. PubMed ID: 35244402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docosahexaenoic acid enhances the treatment efficacy for castration-resistant prostate cancer by inhibiting autophagy through Atg4B inhibition.
    Kudo Y; Nakamura K; Tsuzuki H; Hirota K; Kawai M; Takaya D; Fukuzawa K; Honma T; Yoshino Y; Nakamura M; Shiota M; Fujimoto N; Ikari A; Endo S
    Arch Biochem Biophys; 2024 Oct; 760():110135. PubMed ID: 39181384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new quinoline-based chemical probe inhibits the autophagy-related cysteine protease ATG4B.
    Bosc D; Vezenkov L; Bortnik S; An J; Xu J; Choutka C; Hannigan AM; Kovacic S; Loo S; Clark PGK; Chen G; Guay-Ross RN; Yang K; Dragowska WH; Zhang F; Go NE; Leung A; Honson NS; Pfeifer TA; Gleave M; Bally M; Jones SJ; Gorski SM; Young RN
    Sci Rep; 2018 Aug; 8(1):11653. PubMed ID: 30076329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of New ATG4B Inhibitors Based on a Novel High-Throughput Screening Platform.
    Xu D; Xu Z; Han L; Liu C; Zhou Z; Qiu Z; Lin X; Tang G; Shen H; Aebi J; Riemer C; Kuhn B; Stahl M; Mark D; Qin N; Ding H
    SLAS Discov; 2017 Apr; 22(4):338-347. PubMed ID: 26993319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors.
    Akin D; Wang SK; Habibzadegah-Tari P; Law B; Ostrov D; Li M; Yin XM; Kim JS; Horenstein N; Dunn WA
    Autophagy; 2014; 10(11):2021-35. PubMed ID: 25483883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a small molecule targeting autophagy via ATG4B inhibition and cell death of colorectal cancer cells in vitro and in vivo.
    Fu Y; Hong L; Xu J; Zhong G; Gu Q; Gu Q; Guan Y; Zheng X; Dai Q; Luo X; Liu C; Huang Z; Yin XM; Liu P; Li M
    Autophagy; 2019 Feb; 15(2):295-311. PubMed ID: 30176161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ATG4B inhibitor blocks autophagy and sensitizes Sorafenib inhibition activities in HCC tumor cells.
    Xie Y; Fan S; Ni D; Wan W; Xu P; Ding Y; Zhang R; Lu J; Zhang N; Zhang Y; Xiao W; Zhao K; Luo C
    Bioorg Med Chem; 2023 Apr; 84():117262. PubMed ID: 37018878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Context-dependent role of ATG4B as target for autophagy inhibition in prostate cancer therapy.
    Tran E; Chow A; Goda T; Wong A; Blakely K; Rocha M; Taeb S; Hoang VC; Liu SK; Emmenegger U
    Biochem Biophys Res Commun; 2013 Nov; 441(4):726-31. PubMed ID: 24184480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor screening and enzymatic activity determination for autophagy target Atg4B using a gel electrophoresis-based assay.
    Cleenewerck M; Grootaert MOJ; Gladysz R; Adriaenssens Y; Roelandt R; Joossens J; Lambeir AM; De Meyer GRY; Declercq W; Augustyns K; Martinet W; Van der Veken P
    Eur J Med Chem; 2016 Nov; 123():631-638. PubMed ID: 27517808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice.
    Kurdi A; Cleenewerck M; Vangestel C; Lyssens S; Declercq W; Timmermans JP; Stroobants S; Augustyns K; De Meyer GRY; Van Der Veken P; Martinet W
    Biochem Pharmacol; 2017 Aug; 138():150-162. PubMed ID: 28642033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAcylation of ATG4B positively regulates autophagy by increasing its hydroxylase activity.
    Jo YK; Park NY; Park SJ; Kim BG; Shin JH; Jo DS; Bae DJ; Suh YA; Chang JH; Lee EK; Kim SY; Kim JC; Cho DH
    Oncotarget; 2016 Aug; 7(35):57186-57196. PubMed ID: 27527864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy impairment mediated by S-nitrosation of ATG4B leads to neurotoxicity in response to hyperglycemia.
    Li Y; Zhang Y; Wang L; Wang P; Xue Y; Li X; Qiao X; Zhang X; Xu T; Liu G; Li P; Chen C
    Autophagy; 2017 Jul; 13(7):1145-1160. PubMed ID: 28633005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.
    Chen Z; Jiang Q; Zhu P; Chen Y; Xie X; Du Z; Jiang L; Tang W
    Prostate; 2019 Jan; 79(1):44-53. PubMed ID: 30178500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined N-terminal androgen receptor and autophagy inhibition increases the antitumor effect in enzalutamide sensitive and enzalutamide resistant prostate cancer cells.
    Kranzbühler B; Salemi S; Mortezavi A; Sulser T; Eberli D
    Prostate; 2019 Feb; 79(2):206-214. PubMed ID: 30345525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems biology-based discovery of a potential Atg4B agonist (Flubendazole) that induces autophagy in breast cancer.
    Zhang L; Guo M; Li J; Zheng Y; Zhang S; Xie T; Liu B
    Mol Biosyst; 2015 Nov; 11(11):2860-6. PubMed ID: 26299935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATG4B inhibitor FMK-9a induces autophagy independent on its enzyme inhibition.
    Chu J; Fu Y; Xu J; Zheng X; Gu Q; Luo X; Dai Q; Zhang S; Liu P; Hong L; Li M
    Arch Biochem Biophys; 2018 Apr; 644():29-36. PubMed ID: 29510087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLC27A4 regulate ATG4B activity and control reactions to chemotherapeutics-induced autophagy in human lung cancer cells.
    Wu S; Su J; Qian H; Guo T
    Tumour Biol; 2016 May; 37(5):6943-52. PubMed ID: 26662804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and mechanism studies of a novel ATG4B inhibitor Ebselen by drug repurposing and its anti-colorectal cancer effects in mice.
    Xie H; Qiang P; Wang Y; Xia F; Liu P; Li M
    Cell Biosci; 2022 Dec; 12(1):206. PubMed ID: 36539845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of fluorescent substrates and assays for the key autophagy-related cysteine protease enzyme, ATG4B.
    Nguyen TG; Honson NS; Arns S; Davis TL; Dhe-Paganon S; Kovacic S; Kumar NS; Pfeifer TA; Young RN
    Assay Drug Dev Technol; 2014 Apr; 12(3):176-89. PubMed ID: 24735444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Atg4B for cancer therapy: Chemical mediators.
    Yang G; Li Y; Zhao Y; Ouyang L; Chen Y; Liu B; Liu J
    Eur J Med Chem; 2021 Jan; 209():112917. PubMed ID: 33077263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.